Efficacy of One or Two Botulinum Toxin Injections in the Treatment of Chronic Lateral Epicondylalgia: a Retrospective Study (EPITOX)

Regional University Hospital Center (CHRU)

Status: Active, not recruiting

Conditions: Lateral Epicondylitis

Treatments: Drug: Botulinum toxin injection

Study type: Observational

Funder types: Other

Identifiers

NCT06765694

29BRC24.0278 - EPITOX

Details and patient eligibility

About

Despite being a self-limiting injury, lateral epicondylitis (LE) can be difficult to manage. In cases of refractory LE, conservative treatment fails and symptoms persist over 6 months. Previous studies have investigated the role of botulinum Toxin Type A (BoNT-A) injections in LE with controversial results. There is some evidence that repeating the BoNT-A injection could be beneficial for refractory cases.

The objective is to assess the success rate of one or two BoNT-A injections for refractory LE.

Enrollment: 80 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

lateral epicondylitis at least one botulinum injection

Exclusion criteria

• none

Trial design

80 participants in 1 patient group

epicondylitis with BTX injection

Description:

Subjects included were addressed to a unique physician who performed all the treatment procedure with a diagnostic of lateral epicondylitis to receive a BTX injection.

Treatment:

Drug: Botulinum toxin injection